OCTAVE SPECIALTY GROUP INC 8-K

What Happened

• Octave Specialty Group Inc. filed an 8-K (Apr 7, 2026) reporting a First Amendment to its Credit Agreement (originally dated Oct. 31, 2025) with lenders and Truist Bank as administrative agent. The amendment provides an additional term loan of $40,000,000 that is fully fungible with the existing term loan and carries the same maturity date and interest rate.
• After the amendment, total outstanding term loans are $139,375,000 as of April 1, 2026. As part of the amendment, the Company pledged its ownership interests in Everspan Holdings, LLC. The proceeds will be used, among other things, to fund Cirrata V UK Limited’s (Cirrata UK) obligation to honor put rights exercised in March 2026 by certain minority shareholders of Octave Specialty Limited.

Key Details

• Additional Term Loan: $40,000,000 (same class/tranche, rate, and maturity as existing term loan).
• Total outstanding term loans: $139,375,000 (as of April 1, 2026).
• Collateral: Company pledged ownership interests in Everspan Holdings, LLC.
• Use of proceeds: To fund Cirrata UK’s payment obligations under put rights exercised in March 2026 by minority shareholders of Octave Specialty Limited.

Why It Matters

• The amendment increases the company’s outstanding term debt and establishes a new collateral pledge (Everspan Holdings ownership), both of which are material balance-sheet developments disclosed to investors.
• Proceeds are earmarked to satisfy a specific cash obligation (put rights exercised in March 2026), indicating a financing response to that liability.
• The Company will file the full First Amendment as an exhibit to its Form 10-Q for the quarter ended June 30, 2026; investors should review that exhibit for the complete terms and any covenant changes.